Yingpeng Huang

Wenzhou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 26 publications

U07, a novel oridonin derivative, targets polo-like kinase 4 (PLK4) to induce ferroptosis in gastric cancer cells.

U07, a novel oridonin derivative, targets polo-like kinase 4 (PLK4) to induce ferroptosis in gastric cancer cells.

Journal: Biochemical pharmacology

Published: November 03, 2025

Synergistic Activation of Immunogenic Cell Death and the cGAS-STING Pathway by Engineered Zinc/Manganese-Based Metal-Organic Framework Nanoplatforms for Colon Cancer Immunotherapy.

Synergistic Activation of Immunogenic Cell Death and the cGAS-STING Pathway by Engineered Zinc/Manganese-Based Metal-Organic Framework Nanoplatforms for Colon Cancer Immunotherapy.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: October 23, 2025

An Fe(III)-covalent organic framework (COF)-sorafenib nanoplatform induces chemo-ferroptosis for enhanced hepatocellular carcinoma immunotherapy.

An Fe(III)-covalent organic framework (COF)-sorafenib nanoplatform induces chemo-ferroptosis for enhanced hepatocellular carcinoma immunotherapy.

Journal: Materials today. Bio

Published: June 01, 2025

Prokaryotic organelle mitochondria drive tumorigenesis: "the original sin".

Prokaryotic organelle mitochondria drive tumorigenesis: "the original sin".

Journal: Frontiers in oncology

Published: May 21, 2025

Hyaluronic acid-modified doxorubicin-covalent organic framework nanoparticles triggered pyroptosis in combinations with immune checkpoint blockade for the treatment of breast cancer.

Hyaluronic acid-modified doxorubicin-covalent organic framework nanoparticles triggered pyroptosis in combinations with immune checkpoint blockade for the treatment of breast cancer.

Journal: International journal of biological macromolecules

Published: February 19, 2025

Comprehensive landscape of gastric cancer-targeted therapy and identification of CSNK2A1 as a potential target.

Comprehensive landscape of gastric cancer-targeted therapy and identification of CSNK2A1 as a potential target.

Journal: Heliyon

Published: April 03, 2024

Elesclomol Loaded Copper Oxide Nanoplatform Triggers Cuproptosis to Enhance Antitumor Immunotherapy.

Elesclomol Loaded Copper Oxide Nanoplatform Triggers Cuproptosis to Enhance Antitumor Immunotherapy.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: December 19, 2023

Reduced Proline-Rich Tyrosine Kinase 2 Promotes Tumor Metastasis by Activating Epithelial-Mesenchymal Transition in Colorectal Cancer.

Reduced Proline-Rich Tyrosine Kinase 2 Promotes Tumor Metastasis by Activating Epithelial-Mesenchymal Transition in Colorectal Cancer.

Journal: Digestive diseases and sciences

Published: September 20, 2023

Machine Learning Radiomics Liver Function Model for Prognostic Prediction After Radical Resection of Advanced Gastric Cancer: A Retrospective Study.

Machine Learning Radiomics Liver Function Model for Prognostic Prediction After Radical Resection of Advanced Gastric Cancer: A Retrospective Study.

Journal: Annals of surgical oncology

Published: August 16, 2023

LncRNA FBXO18-AS promotes gastric cancer progression by TGF-β1/Smad signaling.

LncRNA FBXO18-AS promotes gastric cancer progression by TGF-β1/Smad signaling.

Journal: European journal of histochemistry : EJH

Published: February 02, 2023

Genomic instability-related twelve-microRNA signatures for predicting the prognosis of gastric cancer.

Genomic instability-related twelve-microRNA signatures for predicting the prognosis of gastric cancer.

Journal: Computers in biology and medicine

Published: November 13, 2022

Butyrate Inhibits Gastric Cancer Cells by Inducing Mitochondriamediated Apoptosis.

Butyrate Inhibits Gastric Cancer Cells by Inducing Mitochondriamediated Apoptosis.

Journal: Combinatorial chemistry & high throughput screening

Published: March 18, 2022

Showing 1-12 of 26

Last Updated: 09/26/2026